Apr 14, 2024, 15:19
Eddie Cliff: Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs
Eddie Cliff, Research Fellow at
“Delighted to present our work at AACR24 today, led by Ian Liu, on oncology accelerated approvals, simultaneously published at JAMA.
Accelerated approval is a useful program but has a long way to go to ensure it delivers high-value drugs.”
Read further.
Source: Eddie Cliff/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54